谷歌浏览器插件
订阅小程序
在清言上使用

Supplementary Table S1 and Figure Legends from Personalized Preclinical Trials in BRAF Inhibitor–Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies

crossref(2023)

引用 0|浏览3
暂无评分
摘要
Supplementary Table S1: Summary of melanoma patients with clinical follow-up. Figure Legends
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要